OOIR: Observatory of International Research

Papers

(The H4-Index of Best Practice & Research Clinical Endocrinology & Metabolism is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Editorial Board	145
Editorial Board	85
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	73
Editorial Board	69
Thiazide-induced hyponatremia	66
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	60
Surgery for prolactinoma	59
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?	57
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”	53
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	52
The role of androgens in transgender medicine	45
Sexual health and contraception in the menopause journey	42
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	41
Coronavirus disease 2019 and vitamin D	39
Editorial Board	35
Immune checkpoint inhibitor-related thyroid dysfunction	35
Impulse control disorders and dopamine agonists	33
Editorial Board	32
Cardiometabolic outcomes of early onset hypogonadism in males	31
Remnant lipoprotein particles and cardiovascular disease risk	31
Haematological actions of androgens	31
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications	30
Editorial Board	30
Type 1 diabetes related to immune checkpoint inhibitors	29
Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis	27

Epidemiology and risk factors for hypopituitarism due to traumatic brain injury	27
Radioiodine therapy in the different stages of differentiated thyroid cancer	27
Medullary thyroid cancer - An update	27